Skip to main navigation Skip to search Skip to main content

Safety of vaccination of patients with systemic lupus erythematosus

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Live vaccines are not safe for immuno-compromised patients and should not be given to patients with systemic lupus erythematosus. In addition, all vaccines are not recommended for systemic lupus erythematosus patients when their disease is very active and mainly for patients with very active lupus nephritis. Systemic lupus erythematosus patients with quiescent or mildly active disease should be encouraged to receive vaccination according the recommendations given by the Immunization Practices Advisory Committee. Among this group of systemic lupus erythematosus patients, vaccines are safe and they do not affect the clinical manifestations of systemic lupus erythematosus including renal features, disease activity, or the requirement for steroids or cytotoxic drugs. However, vaccines may trigger the generation of autoantibodies which is usually short term and has no clinical significance. In individual cases vaccines exacerbate systemic lupus erythematosus; however, no specific clinical or laboratory variables have been identified to be associated with flare of systemic lupus erythematosus following vaccination.

Original languageEnglish
Pages (from-to)1205-1208
Number of pages4
JournalLupus
Volume18
Issue number13
DOIs
StatePublished - 16 Nov 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Autoantibodies
  • Influenza
  • SLE
  • SLEDAI
  • Vaccination

ASJC Scopus subject areas

  • Rheumatology

Fingerprint

Dive into the research topics of 'Safety of vaccination of patients with systemic lupus erythematosus'. Together they form a unique fingerprint.

Cite this